Endocyte, Inc. (ECYT) Tops Q1 EPS by 5c; Reports Halt of PROCEED Trial (MRK)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Endocyte (ECYT) Removed from Wedbush's Best Ideas List
May 5, 2014 10:21 AM EDTWedbush maintained an Outperform rating on Endocyte (NASDAQ: ECYT) but removed the stock from its Best Ideas List. Its price target was reduced to $26.00 (from $65.00).
Analyst Gregory R. Wade said, "The Data Safety... More
Baird Downgrades Endocyte (ECYT) to Neutral
May 2, 2014 10:17 AM EDTBaird downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral with a price target of $8.00.
For an analyst ratings summary and ratings history on Endocyte click here. For more ratings news on Endocyte click here.
Shares of Endocyte closed at $17.38 yesterday.
... MorePiper Jaffray Downgrades Endocyte (ECYT) to Neutral
May 2, 2014 9:03 AM EDTPiper Jaffray downgraded Endocyte (NASDAQ: ECYT) from Overweight to Neutral with a price target of $13.50.
For an analyst ratings summary and ratings history on Endocyte click here. For more ratings news on Endocyte click here.
Shares of Endocyte closed at $17.38 yesterday.
... MoreEndocyte, Inc. (ECYT) trading halted with news pending
May 2, 2014 7:57 AM EDTEndocyte, Inc. (NASDAQ: ECYT) trading halted with news pending.
... More